While the desirability of having a dangerous drug on the market is debatable in comparison to what might happen to patients that don't have it, that's nothing I've been disputing. What I've been defending is Rodney's suggestion that drugs are and have been prescribed without doctors or patients being aware of what those risks are, and my future interpretation/elaboration that in the case of Vioxx, that occurred in a manner that was preventable. It took an inordinate amount of time to get proper labeling on the packaging and literature for Vioxx detailing the discovered risks after they were known. Patients, who are not expected to be aware of all the details, were heavily marketed toward and the risks downplayed, not mentioned, or claimed to be an effect of all NSAIDs before any such claim could be verified. Doctors, while fully capable of reading all the papers produced concerning the drug, were still subjected to calls from Merck explaining away objections raised by those studies with arguments and downplaying negative interpretations, even as the company was aware that evidence continued to mount against it's own official line.